+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hemostasis Diagnostics Market - Global Forecast 2026-2032- Product Image
Hemostasis Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Hemostasis Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887515
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hemostasis diagnostics market is evolving rapidly, driven by demands for faster diagnostics, integrated digital workflows, and resilient supply chain solutions. For senior decision-makers, seizing competitive advantage in this complex arena calls for strategic focus on procurement excellence, innovation alignment, and operational agility.

Market Snapshot: Hemostasis Diagnostics Market

The hemostasis diagnostics market grew from USD 672.05 million in 2025 to USD 728.77 million in 2026. It is expected to expand at a CAGR of 8.44% and reach USD 1.18 billion by 2032, highlighting robust momentum in laboratory and point-of-care adoption worldwide. This trajectory reflects accelerating demand for precise, rapid coagulation testing to support acute care, medication management, and population screening. The ongoing prioritization of these capabilities shapes procurement and investment strategies for providers committed to optimizing patient care and workflow efficiency.

Scope & Segmentation

This report delivers in-depth analysis across the full hemostasis diagnostics value chain, organized into several critical areas:

  • Product Classes: Coverage includes high-throughput automated analyzers and decentralized devices for diverse clinical settings; associated reagents and consumable kits; laboratory software solutions and information systems that connect clinical workflows; and essential services such as calibration, maintenance, and training.
  • Analytical Technologies: Details on chromogenic and clotting assays for a range of coagulation factors; immunologic assays that target conditions like thrombophilia; and advanced molecular platforms, including PCR-based and genetic analysis, used for complex profiling.
  • End User Environments: Assessment spans hospital and independent laboratories, tertiary academic centers, community clinics, and research institutes focused on translational and population-based health initiatives.
  • Clinical Applications: Analysis includes solutions for bleeding disorder diagnostics, management of coagulation abnormalities (such as disseminated intravascular coagulation), routine screening—including prenatal and population-based—and therapy monitoring for patients on oral anticoagulants or heparin.
  • Geographic Regions: Comprehensive market evaluation covering the Americas, Europe, Middle East & Africa, and Asia-Pacific, with emphasis on regional regulatory environments, procurement processes, and infrastructure maturity influencing adoption.

Key Takeaways for Senior Decision-Makers

  • Integrating new assay modalities—especially molecular and immunological—with established coagulation tests is now fundamental for advanced clinical workflows and diagnostic reliability.
  • Laboratory digitalization, including integration of information systems, is enhancing longitudinal patient tracking and enabling more personalized care and decision-making.
  • Organizations are restructuring procurement to address supply chain risks, diversifying suppliers, and expanding regional sourcing as ways to mitigate cost fluctuations and delivery challenges.
  • Service-focused models such as reagent rental agreements and bundled maintenance deliver predictability in operating costs while supporting instrument reliability and uptime.
  • Collaboration between manufacturers, software providers, and reagent suppliers is producing more seamless, reliable solutions for end-users, strengthening commercial differentiation.
  • Evolving patient screening approaches and new therapies are shifting test volume demands, leading to innovation in menu offerings and flexible service delivery models tailored to different clinical environments.

Tariff Impact on Procurement and Supply Chain

The 2025 implementation of U.S. tariffs has directly shaped procurement approaches and supplier strategies across the hemostasis diagnostics sector. Organizations are now evaluating sourcing models more rigorously, focusing on limiting exposure to cost increases and supply disruptions. This trend is prompting alliances with regional manufacturers, stringent validation of alternative reagents and devices, and the growing utilization of commercial models such as reagent rental agreements that stabilize expenses and reinforce supplier performance. These adaptive strategies are designed to support operational continuity and cost management amid changing tariff and supply chain landscapes.

Methodology & Data Sources

The report applies a mixed-methods approach, combining detailed interviews with clinical laboratory directors, procurement leaders, and academic researchers with thorough secondary research from peer-reviewed sources and regulatory publications. Analytical segmentation was used to map evolving product, technology, and regional trends, and all findings have been reviewed by subject matter experts to assure clinical and technical accuracy.

Why This Report Matters

  • Provides actionable insight for aligning diagnostic innovation, supply chain planning, and commercial approaches to evolving care and operational requirements.
  • Enables executive teams to benchmark procurement and partnership best practices across markets for improved resilience and efficiency.
  • Delivers a robust foundation for data-driven decision-making by integrating practitioner feedback and regulatory trends with comprehensive market analysis.

Conclusion

Success in the hemostasis diagnostics market depends on harmonizing analytical technology, digital integration, and robust service frameworks. Adaptive strategies that address supply chain, regulatory, and clinical complexity will best position organizations for sustainable growth and partnership in an evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Hemostasis Diagnostics Market, by Product
8.1. Instruments And Analyzers
8.1.1. Automated Analyzers
8.1.2. Point Of Care Instruments
8.2. Reagents And Kits
8.2.1. Consumables
8.2.2. Ready To Use Kits
8.3. Software And Services
8.3.1. Laboratory Information Systems
8.3.2. Maintenance And Support Services
8.3.2.1. Calibration
8.3.2.2. Preventive Maintenance
8.3.2.3. Training
9. Hemostasis Diagnostics Market, by Technology
9.1. Chromogenic Assay
9.1.1. Factor VIII Assay
9.1.2. Factor X Assay
9.1.3. Thrombin Inhibition Assay
9.2. Clotting Assay
9.2.1. Activated Partial Thromboplastin Time
9.2.2. Fibrinogen Assay
9.2.3. Prothrombin Time
9.2.4. Thrombin Time
9.3. Immunologic Assay
9.3.1. Antiphospholipid Antibodies
9.3.2. D Dimer
9.3.3. Protein C S
9.4. Molecular Assay
9.4.1. Genotyping Tests
9.4.2. Pcr Based Tests
10. Hemostasis Diagnostics Market, by End User
10.1. Diagnostic Laboratories
10.1.1. Hospital Based Labs
10.1.2. Independent Labs
10.2. Hospitals And Clinics
10.2.1. Secondary Care Hospitals
10.2.2. Tertiary Care Hospitals
10.3. Research Institutes
11. Hemostasis Diagnostics Market, by Application
11.1. Disease Diagnosis
11.1.1. Bleeding Disorders
11.1.2. D I C
11.1.3. Thrombophilia
11.2. Screening And Prevention
11.2.1. Population Screening
11.2.2. Prenatal Screening
11.3. Treatment Monitoring
11.3.1. Anticoagulant Therapy Monitoring
11.3.2. Doac
11.3.3. Heparin
11.3.4. Warfarin
12. Hemostasis Diagnostics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Hemostasis Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Hemostasis Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Hemostasis Diagnostics Market
16. China Hemostasis Diagnostics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. ARUP Laboratories
17.7. Becton, Dickinson and Company
17.8. Bio-Rad Laboratories, Inc.
17.9. bioMérieux SA
17.10. Danaher Corporation
17.11. Diagnostica Stago SAS
17.12. F. Hoffmann-La Roche Ltd.
17.13. Grifols, S.A.
17.14. Haemonetics Corporation
17.15. Helena Laboratories Corporation
17.16. HORIBA Group
17.17. Instrumentation Laboratory Company
17.18. Laboratory Corporation of America Holdings
17.19. Medtronic PLC
17.20. Merck & Co., Inc.
17.21. Ortho Clinical Diagnostics Holdings, LLC
17.22. Randox Laboratories Ltd.
17.23. Siemens AG
17.24. Stago Group
17.25. Sysmex America, Inc.
17.26. Thermo Fisher Scientific Inc.
17.27. Werfen, S.A.
List of Figures
FIGURE 1. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY AUTOMATED ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POINT OF CARE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY READY TO USE KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY READY TO USE KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY READY TO USE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY LABORATORY INFORMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CALIBRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CALIBRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CALIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PREVENTIVE MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PREVENTIVE MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PREVENTIVE MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR VIII ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR VIII ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR VIII ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR X ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR X ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FACTOR X ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN INHIBITION ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN INHIBITION ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN INHIBITION ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY FIBRINOGEN ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTHROMBIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN TIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTIPHOSPHOLIPID ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D DIMER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTEIN C S, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTEIN C S, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PROTEIN C S, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GENOTYPING TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GENOTYPING TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY GENOTYPING TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PCR BASED TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PCR BASED TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PCR BASED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITAL BASED LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY BLEEDING DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY BLEEDING DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY BLEEDING DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D I C, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D I C, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY D I C, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBOPHILIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBOPHILIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY THROMBOPHILIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POPULATION SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY POPULATION SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRENATAL SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRENATAL SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTICOAGULANT THERAPY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTICOAGULANT THERAPY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY ANTICOAGULANT THERAPY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DOAC, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DOAC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DOAC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HEPARIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HEPARIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY WARFARIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY WARFARIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY WARFARIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 165. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 166. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 167. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 169. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 179. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 181. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 182. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 183. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 184. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 197. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 199. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 233. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 235. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 237. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 238. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 239. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 241. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 242. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 243. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 244. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 246. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 247. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 249. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 250. EUROPE HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 260. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 261. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 262. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 264. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 265. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 267. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 268. MIDDLE EAST HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 269. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 271. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 272. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 273. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 274. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 275. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 276. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 277. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 278. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 279. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 280. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 282. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 283. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 284. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 285. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 286. AFRICA HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TREATMENT MONITORING, 2018-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS AND ANALYZERS, 2018-2032 (USD MILLION)
TABLE 290. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
TABLE 291. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 292. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MAINTENANCE AND SUPPORT SERVICES, 2018-2032 (USD MILLION)
TABLE 293. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 294. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAY, 2018-2032 (USD MILLION)
TABLE 295. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY CLOTTING ASSAY, 2018-2032 (USD MILLION)
TABLE 296. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGIC ASSAY, 2018-2032 (USD MILLION)
TABLE 297. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY MOLECULAR ASSAY, 2018-2032 (USD MILLION)
TABLE 298. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 300. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
TABLE 301. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 302. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2032 (USD MILLION)
TABLE 303. ASIA-PACIFIC HEMOSTASIS DIAGNOSTICS MARKET SIZE, BY SCREENING AND PREVENTION, 2018-2032 (USD MILLION)
TABLE 304. ASIA-PACIFIC HEM

Companies Mentioned

The key companies profiled in this Hemostasis Diagnostics market report include:
  • Abbott Laboratories
  • ARUP Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • Haemonetics Corporation
  • Helena Laboratories Corporation
  • HORIBA Group
  • Instrumentation Laboratory Company
  • Laboratory Corporation of America Holdings
  • Medtronic PLC
  • Merck & Co., Inc.
  • Ortho Clinical Diagnostics Holdings, LLC
  • Randox Laboratories Ltd.
  • Siemens AG
  • Stago Group
  • Sysmex America, Inc.
  • Thermo Fisher Scientific Inc.
  • Werfen, S.A.

Table Information

Report AttributeDetails
No. of Pages185
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 728.77 Million
Forecasted Market Value ( USD ) by 2032 $ 1180 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Coagulation & Hemostasis Testing Market - Global Forecast 2026-2032 - Product Image

Coagulation & Hemostasis Testing Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Hemostasis Diagnostic Devices and Equipment Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Hemostasis Diagnostic Devices and Equipment Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Hemostasis Diagnostic Devices and Equipment Market Report 2025 - Product Image

Hemostasis Diagnostic Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Hemostasis Diagnostics - Global Strategic Business Report - Product Image

Hemostasis Diagnostics - Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
Hemostasis Market Report and Forecast 2025-2034 - Product Image

Hemostasis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From

About the Hemostasis Test Market

The Hemostasis Test market is a subset of the larger Coagulation and Hemostasis Testing market. Hemostasis Tests are used to measure the ability of the body to form clots and stop bleeding. These tests are used to diagnose and monitor a variety of conditions, including bleeding disorders, thrombosis, and other clotting-related diseases. Hemostasis Tests are typically performed in a laboratory setting, using a variety of methods, including manual and automated techniques. The Hemostasis Test market is highly competitive, with a number of companies offering a range of products and services. These include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, and Beckman Coulter. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.